Bio

Clinical Focus


  • Pediatric Infectious Diseases

Academic Appointments


Professional Education


  • Board Certification: American Board of Pediatrics, Pediatric Infectious Diseases (2009)
  • Fellowship: UCLA Mattel Children's Hospital Pediatric Infectious Disease Prgm (2008) CA
  • Board Certification: American Board of Pediatrics, Pediatrics (2005)
  • Residency: UCLA Pediatric Residency (2005) CA
  • Medical Education: Columbia University College of Physicians and Surgeons (2002) NY

Publications

All Publications


  • An Observational Study of Severe Pertussis in 100 Infants 120 Days of Age PEDIATRIC INFECTIOUS DISEASE JOURNAL Cherry, J. D., Wendorf, K., Bregman, B., Lehman, D., Nieves, D., Bradley, J. S., Mason, W. H., Sande-Lopez, L., Lopez, M., Federman, M., Chen, T., Blumberg, D., Johnston, S., Schwenk, H. T., Weintrub, P., Quinn, K. K., Winter, K., Harriman, K. 2018; 37 (3): 202?5

    Abstract

    Pertussis in young infants is a unique, severe, afebrile, cough illness that is frequently fatal.All pertussis cases ?120 days of age admitted to a pediatric intensive care unit in California between October 1, 2013, and April 25, 2015, were evaluated.Of 100 pertussis patients ?120 days of age admitted to pediatric intensive care unit, there were 5 deaths. The white blood cell counts in the fatal cases were significantly higher than in the nonfatal cases. Thirty-four percent of patients were intubated, 18% received inotropic and/or vasoactive support, 22% received steroid, 4% received extracorporal membrane oxygenation, and 3% underwent exchange blood transfusion. The median age at the time of illness onset in the patients who died was 23 days.These data, as well as data from previous California studies, suggest updated strategies for the management of severe pertussis. These include perform serial white blood cell counts, treat all presumptive cases with azithromycin, evaluate for pulmonary hypertension, intubate and administer oxygen for apneic episodes and administer inotropic/vasoactive agents for cardiogenic shock. Do not administer steroids or nitric oxide. Criteria for exchange blood transfusion therapy for leukocytosis with lymphocytosis are suggested.

    View details for DOI 10.1097/INF.0000000000001710

    View details for Web of Science ID 000426088200010

    View details for PubMedID 28737623

Footer Links:

Stanford Medicine Resources: